Concepedia

Publication | Closed Access

Enhanced Delivery of SN-38 to Human Tumor Xenografts with an Anti-Trop-2–SN-38 Antibody Conjugate (Sacituzumab Govitecan)

DOI

161

Citations

26

References

2015

Year

Robert M. Sharkey, William J. McBride, Thomas M. Cardillo, Serengulam V. Govindan, Yang Wang, Edmund A. Rossi, Chien‐Hsing Chang, David M. Goldenberg
Clinical Cancer Research

Abstract

These studies confirm a superior SN-38 tumor delivery by IMMU-132 compared with irinotecan.

References

YearCitations

Page 1